Federal lawsuits against Allergan’s Natrelle Biocell Textured Breast Implants emerged months after its manufacturer, Allergan, recalled it. The U.S. Judicial Panel on Multidistrict Litigation consolidated all federal into an MDL class action in New Jersey (most recent court order). The MDL lawsuits allege that the implants cause breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a rare form of cancer.
August 21, 2023: A woman from Delaware County, Pennsylvania, just outside Philadelphia, became one of the most recent plaintiffs to file a case in the Allergan breast implants class action lawsuit. According to the Complaint, which was filed directly in the Allergan MDL earlier this month, the plaintiff got Allergan silicone-filled breast implants in 2015 and they had to be removed 4 years later. The plaintiff has not been diagnosed with cancer yet, but her lawsuit alleges that the breast implants significantly increased her risk of developing cancer in the future, and caused emotional suffering.